Skip to Content

655 (Glyburide and Metformin Hydrochloride 5 mg / 500 mg)

Pill with imprint 655 is Yellow, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 655

Glyburide and metformin hydrochloride 5 mg / 500 mg 655

Glyburide and Metformin Hydrochloride

Imprint
655
Strength
5 mg / 500 mg
Color
Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cadila Healthcare Limited
National Drug Code (NDC)
65841-0826
Inactive Ingredients
calcium carbonate, microcrystalline cellulose, croscarmellose sodium, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, hypromellose 2910 (15 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 4000, povidone k29/32, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "655"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.